FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159157323> ?p ?o ?g. }

• W3159157323 abstract "Background There are no clear consensus guidelines on the indications and types of anticoagulation therapies in patients with bio-prosthetic valves either with concomitant atrial fibrillation (AF) or sinus rhythm. In our meta-analysis, we assessed the safety and efficacy of DOACs as compared to the standard treatment with warfarin in patients with AF and bioprosthetic valves. Methods We included randomized controlled trials (RCTs), cohort studies in the English language, and studies reporting patients with valvular heart disease that included bioprosthetic valvular disease. A systematic literature review using Embase, PubMed, and Web of Science was performed using the terms “Direct Acting Oral Anticoagulant,” “Oral Anticoagulants,” “Non-Vitamin K Antagonist Oral Anticoagulant,” “Atrial Fibrillation,” “Bioprosthetic Valve” for literature published prior to January 2021. Extraction of data from included studies was carried out independently by three reviewers from Covidence. We assessed the methodical rigor of the included studies using the modified Downs and Black checklist. Results Four RCTs and one observational study (n=1776) were included in our study. A random-effect model using RevMan (version 5.4; The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen) was used for data analysis. The pooled data showed that there was a non-significant reduction in the incidence of stroke and systemic embolism in the patients taking DOACs as compared to warfarin (HR 0.69; 95% CI, 0.29, 1.67; I2 = 50%). The incidence of major bleeding was lower in the DOACs group; the difference was statistically significant (HR 0.42; 95% CI, 0.26, 0.67; I2 = 7%). The difference was not statistically significant for all-cause mortality in both groups (HR 1.24; 95% CI, 0.91, 1.67; I2 = 0%). Conclusion Our results showed that there was no difference in the outcomes of stroke and systemic embolism between DOACs and warfarin but there were statistically significantly lower major bleeding events. We conclude that larger clinical trials are needed to assess the true safety and efficacy of DOACs in patients with AF and bioprosthetic valves." @default.
• W3159157323 created "2021-05-10" @default.
• W3159157323 creator A5011918442 @default.
• W3159157323 creator A5021030272 @default.
• W3159157323 creator A5021540824 @default.
• W3159157323 creator A5021709235 @default.
• W3159157323 creator A5037296271 @default.
• W3159157323 creator A5043907474 @default.
• W3159157323 creator A5060564317 @default.
• W3159157323 creator A5065130448 @default.
• W3159157323 creator A5073699149 @default.
• W3159157323 creator A5086114260 @default.
• W3159157323 date "2021-04-23" @default.
• W3159157323 modified "2023-10-14" @default.
• W3159157323 title "Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves?" @default.
• W3159157323 cites W1735241258 @default.
• W3159157323 cites W1992718717 @default.
• W3159157323 cites W2022719552 @default.
• W3159157323 cites W2043141255 @default.
• W3159157323 cites W2118168408 @default.
• W3159157323 cites W2123383272 @default.
• W3159157323 cites W2170350621 @default.
• W3159157323 cites W2170852352 @default.
• W3159157323 cites W2267354991 @default.
• W3159157323 cites W2275481599 @default.
• W3159157323 cites W2283535237 @default.
• W3159157323 cites W2588405059 @default.
• W3159157323 cites W2749348258 @default.
• W3159157323 cites W2751063634 @default.
• W3159157323 cites W2912139642 @default.
• W3159157323 cites W2924643363 @default.
• W3159157323 cites W3007610448 @default.
• W3159157323 cites W3034331236 @default.
• W3159157323 cites W3098781229 @default.
• W3159157323 cites W3113150315 @default.
• W3159157323 cites W4231839200 @default.
• W3159157323 doi "https://doi.org/10.7759/cureus.14651" @default.
• W3159157323 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8141356" @default.
• W3159157323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34046282" @default.
• W3159157323 hasPublicationYear "2021" @default.
• W3159157323 type Work @default.
• W3159157323 sameAs 3159157323 @default.
• W3159157323 citedByCount "1" @default.
• W3159157323 countsByYear W31591573232022 @default.
• W3159157323 crossrefType "journal-article" @default.
• W3159157323 hasAuthorship W3159157323A5011918442 @default.
• W3159157323 hasAuthorship W3159157323A5021030272 @default.
• W3159157323 hasAuthorship W3159157323A5021540824 @default.
• W3159157323 hasAuthorship W3159157323A5021709235 @default.
• W3159157323 hasAuthorship W3159157323A5037296271 @default.
• W3159157323 hasAuthorship W3159157323A5043907474 @default.
• W3159157323 hasAuthorship W3159157323A5060564317 @default.
• W3159157323 hasAuthorship W3159157323A5065130448 @default.
• W3159157323 hasAuthorship W3159157323A5073699149 @default.
• W3159157323 hasAuthorship W3159157323A5086114260 @default.
• W3159157323 hasBestOaLocation W31591573231 @default.
• W3159157323 hasConcept C126322002 @default.
• W3159157323 hasConcept C127413603 @default.
• W3159157323 hasConcept C141071460 @default.
• W3159157323 hasConcept C164705383 @default.
• W3159157323 hasConcept C168563851 @default.
• W3159157323 hasConcept C2775914520 @default.
• W3159157323 hasConcept C2776301958 @default.
• W3159157323 hasConcept C2776478404 @default.
• W3159157323 hasConcept C2776704044 @default.
• W3159157323 hasConcept C2779161974 @default.
• W3159157323 hasConcept C2780645631 @default.
• W3159157323 hasConcept C71924100 @default.
• W3159157323 hasConcept C78519656 @default.
• W3159157323 hasConcept C95190672 @default.
• W3159157323 hasConceptScore W3159157323C126322002 @default.
• W3159157323 hasConceptScore W3159157323C127413603 @default.
• W3159157323 hasConceptScore W3159157323C141071460 @default.
• W3159157323 hasConceptScore W3159157323C164705383 @default.
• W3159157323 hasConceptScore W3159157323C168563851 @default.
• W3159157323 hasConceptScore W3159157323C2775914520 @default.
• W3159157323 hasConceptScore W3159157323C2776301958 @default.
• W3159157323 hasConceptScore W3159157323C2776478404 @default.
• W3159157323 hasConceptScore W3159157323C2776704044 @default.
• W3159157323 hasConceptScore W3159157323C2779161974 @default.
• W3159157323 hasConceptScore W3159157323C2780645631 @default.
• W3159157323 hasConceptScore W3159157323C71924100 @default.
• W3159157323 hasConceptScore W3159157323C78519656 @default.
• W3159157323 hasConceptScore W3159157323C95190672 @default.
• W3159157323 hasLocation W31591573231 @default.
• W3159157323 hasLocation W31591573232 @default.
• W3159157323 hasOpenAccess W3159157323 @default.
• W3159157323 hasPrimaryLocation W31591573231 @default.
• W3159157323 hasRelatedWork W1536483153 @default.
• W3159157323 hasRelatedWork W2036754334 @default.
• W3159157323 hasRelatedWork W2097416524 @default.
• W3159157323 hasRelatedWork W2241853559 @default.
• W3159157323 hasRelatedWork W2278916550 @default.
• W3159157323 hasRelatedWork W2320375690 @default.
• W3159157323 hasRelatedWork W2336673794 @default.
• W3159157323 hasRelatedWork W2397305730 @default.
• W3159157323 hasRelatedWork W2415605004 @default.
• W3159157323 hasRelatedWork W2912483181 @default.
• W3159157323 isParatext "false" @default.
• W3159157323 isRetracted "false" @default.

• next